藥物成份

共有 20983 個藥物成份

Anti-C IgM Abs within 0.1%(w/v) NaN3 solution

• 關聯藥證數量: 1

Anti-C3d (Murine Monoclonal) BioClone is prepared by injceting mice intraperitoneally with an anti-C3d secreting hybridoma. After suitable time, the ascitic fluid is havested from the mouse peritoneum and manufactured into a monospecific reagent for sue in detecting C3d.

• 關聯藥證數量: 1

Anti-CA 125 antibody-coated tubes 2 x 50 tubes\n125I-labeled monoclonal antibody: one 33 mL vial\nThe vial contains 480 kBq at time of manufacture of 125I-labeled monoclonal antibody with bovine serum albumin, sodium azide (<0.1%) and a dye.\nStandards: four 1 mL vials + two zero 5 mL vials \nThe standard vials contain between 0 and 400 U/mL of human CA 125 in buffer containing bovine serum albumin and sodium azide (<0.1%).\nControl serum: 1 mL vial\nThe vial contains human CA 125 in human serum with sodium azide (<0.1%).\nWash solution (20X): one 50 mL vial\n\n

• 關聯藥證數量: 1

Anti-CA 15-3 antibody-coated tubes 2 x 50 tubes\n125I-labeled monoclonal antibody: one 22 mL vial\nThe vial contains 600 kBq at time of manufacture of 125I-labeled monoclonal antibody with bovine serum albumin, sodium azide (<0.1%) and a dye.\nStandards: four 2 mL vials + one zero 4 mL vial \nThe standard vials contain between 0 and 250 U/mL of human CA 15-3 in buffer containing bovine serum albumin and sodium azide (<0.1%)\nControl serum: 1 mL vial\nThe vial contains human CA 15-3 in human serum with sodium azide (<0.1%)\nDiluent: one 50 mL vial\nThe vial contains bovine serum albumin in buffer. \n\n \n\n

• 關聯藥證數量: 1

Anti-CEA Plate\nAnti-CEA Peroxidase Conjugate\nCEA Standard 5 ng/ml\nCEA Standard 10 ng/ml\nCEA Standard 30 ng/ml\nCEA Standard 60 ng/ml\nCEA Standard 0 ng/ml\nSpecimen Diluent \n2N Sulfuric Acid\nWashing Solution D (20X) Concentrate\nTMB Substrate Solution A\nTMB Substrate Solution B\n

• 關聯藥證數量: 1

Anti-CEA monoclonal antibody-coated tubes: 2 x 50 tubes 125I-labeled monoclonal anti-CEA antibody: one 22 mL vial The vial contains 640 kBq, at the date of manufacture, of 125I-labeled immunoglobulins in buffer containing bovine serum albumin, sodium azide (<0.1%), and a dye.Calibrators: five 0.5 mL vials and one 6 mL vial of “zero” calibrator The calibrator vials contain from 0 to 400 ng/mL of CEA in buffer with bovineserum albumin and sodium azide (<0.1%).Control sera: two vials The vials contain CEA lyophilised in human serum. Wash solution (20x): one 50 mL vial

• 關聯藥證數量: 1

Anti-D (Monoclonal Blend) Gamma-clone is manufactured by blending the secretions of two human/murine heterohybridomas, grwon in fluid cluture. The IgM (saline-agglutinating) component is contributed by the cell line GAMA-401, and the IgG component by the cell line F8D8.

• 關聯藥證數量: 1

Anti-D serum (Chemically Modified; 1x5 mL): A serum containing reduced and alkylated IgG anti-D, suitable diluted in a proprietary diluent containing tris (hydroxymethyl)-aminomethane buffer and bovine albumin to achieve the appropriate level of potency for the test procedure as described. Any Bovine Albumin used in the manufacture of this product is sourced from donor animals of United States origin that has been inspected and certified by US Veterinary Service inspectors to be disease-free. This ruminant-based product is deemed to have a low-TSE (Transmissible Spongiform Encephalopathy) risk. Contains 0.1% sodium azide as preservative.

• 關聯藥證數量: 1

Anti-Dia prepared from human blood containing appropriate antibodies.

• 關聯藥證數量: 1

Anti-E(Monoclonal) Gamma-clone is manufactured from IgM antibodies of anti-E specificity, secreted by the human/murine heterohybridoma identified as GAMA402. Contains 0.1% sodium azide as a preservative.

• 關聯藥證數量: 1

Anti-FSH monoclonal antibody coated tubes: 2 x 50 tubes 125I-labeled monoclonal anti-FSH antibody: one 5.5 mL vial The vial contains 370 kBq, at the date of manufacture, of 125I labeled immunoglobulins in buffer with proteins, sodium azide (<0.1%; see § Precautions) and a dye.Standards: six 1 mL vials The standard vials contain from 0 to 180 IU/L of human FSH in human serum (see § Precautions). The exact concentration is indicated on each vial. Control sera: two vials (lyophilized)The vials contain human FSH lyophilized in human serum. The expected values are in the concentration range indicated on a supplement.Wash solution (20x): one 50 mL vial

• 關聯藥證數量: 1

Anti-Fyb globulins within 0.1% (W/V) NaN3 solution中.

• 關聯藥證數量: 1

Anti-H(lectin) blood grouping reagent for the saline method is a stabilised extract prepared from the seeds of Ulex Europaeus.

• 關聯藥證數量: 1

Anti-HBs Adjustors (LAHL, LAHH)Two vials (Low and High), 2ml each, of human serum reactive to HBsAg in a buffer, with<0.1 g% sodium azide.LKAH1:1 set. LKAH5:2 sets.Anti-HBs Controls (LAHC1, LAHC2, LAHC3)Three vials (Negative, Low positive and Positive) containing 4ml each.LAHC1(Negative control):One vial containing human serum nonreactive to HBsAg, with<0.1g% sodium azide.LAHC2, LAHC3 (Low positive control, positive control):Two vials containing human serum reactive to HBsAg, with<0.1g% sodium azide.LKAH1:1 set. LAKH5:2 sets.

• 關聯藥證數量: 1

Anti-HBs Bead Pack (Ll2AH12) 200 beads coated with purified inactivated human HBsAg subtypes ad and ayL2KAH2:1 Pack. L2KAH6:3 Packs.Anti-HBs Reagent Wedge (L2AHA2):11.5ml of a protein-based buffer, with<0.1g% sodium azide.11.5ml alkaline phosphatase (bovine calf intestine) conjugated to purified inactivated HBsAg in buffer, with<0.1g% sodium azide.L2KAH2:1 Wedge. L2KAH6:3 Wedges.Anti-HBs Adjustors (LAHL, LAHH):Two vials (Low and High), 2ml each, of human serum reactive to HBsAg in a buffer, with<0.1g% sodium azide. L2KAH2:1 set. L2KAH6:2 sets.Anti-HBs Controls (LAHC1, LAHC2, LAHC3):Three vials (Negative, Low Positive and Positive) containing 4 mL each. LAHC1(Negative Control):One vial containing human serum nonreactive to HBsAg, with<0.1g% sodium azide. LAHC2, LAHC3(Low Positive Control, Positive Control):Two vials containing human serum reactive to HBsAg, with<0.1g% sodium azide.L2KAH2:1 set. L2KAH6:2 sets.

• 關聯藥證數量: 1

Anti-HBs ReadyPack includes:\n(1)Solid Phase 20.0 ml containing inactivaed human HBsAg (ad & ay), covalently coupled to magnetic latex particles in protein buffer with bovine serum albumin, surfactant, and preservatives.\n(2)Lite Reagent 10.0 ml containing inactivated human HBsAg (ad & ay) labeled with acridinium ester in protein buffer with bovine serum albumin, surfactant, and preservatives.\n(3)Ancillary Reagent 10.0 ml containing non-magnetic latex particles in tris buffer with surfactant, and preservatives.\n(4)aHBs calibrator vials: 2.0 ml/vail processed human plasma positive for antibodies to HBsAg with preservatives.\naHBs quality control material containing 10.0 ml/vial processed human plasma negative and positive for antibodies to HBsAg with preservatives.

• 關聯藥證數量: 1

Anti-HBs Test Units(LAH1)Each unit contains one bead coated with purified inactivated human HBsAg subtypes ad and ay.LKAH1:100 units.LKAH5:500 units.Anti-HBs Reagent Wedges (LAHA, LAHB)LAHA:6.5ml consists of a protein-based phosphate buffer, with<0.1g% sodium azide.LAHB:6.5ml alkaline phosphatase (bovine calf intestine) conjugated to purified inactivated HBsAg in buffer, with<0.1g% sodium azide. LKAH1:1 set. LKAH5:5 sets.

• 關聯藥證數量: 1

Anti-HCG monoclonal and polyclonal antibodies.

• 關聯藥證數量: 1

Anti-HLA-DR, clone L243, is derived from the hybridization of mouse NS-1/1-Ag4 myeloma cells with spleen cells from BALB/c mice immunized with the human lymphoblastoid B-cell line RPMI8866.

• 關聯藥證數量: 1

Anti-HSV Reference P/P: Human serum with IgG-antibodies to HSV-antigens in conjunction with\nrheumatoid factors (RF) in Tris buffer solution (20 mmol/L, pH 7.4, with Humanalbin (5 %), approximately 60 %.\nThe nominal value required for the evaluation as well as its upper and lower margins in absorbance units are listed in the barcode table of values.\nPreservatives: approximately 5 mg/L amphotericin B and approximately 100 mg/L gentamicin.\n\nAnti-HSV Reference P/N: Human serum with IgG-antibodies to HSV antigens in Tris buffer solution (20 mmol/L), pH 7.4, with Humanalbin (5 %), approximately 60 %.\nPreservatives: approximately 5 mg/L amphotericin B and approximately 100 mg/L gentamicin.\n\n

• 關聯藥證數量: 1

Anti-IGFBP-3-Coated Microtitration Strips: One stripholder containing 96 microtitration wells coated with goat anti-IGFBP-3 polyclonal antibody.\nIGFBP-3 Standard A/Sample Diluent: containing 0 ng/ml IGFBP-3 in a protein-based (BSA) buffer with a non-mercury preservative.\nIGFBP-3 Standard B-F: Lyophilized.\nIGFBP-3 Controls: Lyophilized.\nIGFBP-3 Assay Buffer: containing a protein-based (BSA) buffer with a non-mercury preservative.\nIGFBP-3 Antibody-Enzyme Conjugate Concentrate: containing goat anti-IGFBP-3 polyclonal antibody conjugated to the enzyme horseradish peroxidase in a protein-based (BSA) buffer with a non-mercury preservative.\nTMB Chromogen Solution: containing a solution of tetramethylbenzidine (TMB) in citrate buffer with hydrogen peroxide.\nWash Concentrate: containing buffered saline with a nonionic detergent.\nStopping Solution: containing 0.2 M sulfuric acid.\n

• 關聯藥證數量: 1

Anti-IGFBP-3-Coated Tubes: \nOne hundred (100) plastic tubes with goat anti-IGFBP-3 polyclonal immunoglobulin immobilized to the inside\nwall of each tube. \nIGFBP-3 Controls:\nTwo vials, Levels I and II, containing low and high levels of IGFBP-3 in a protein-based (BSA) buffer with\nsodium azide as a preservative. \n

• 關聯藥證數量: 1

Anti-IgE Immuno CAP, 3x16

• 關聯藥證數量: 1

Anti-Inhibin A-Coated Microtitration Strips:\nOne stripholders, each containing 96 polystyrene microtiter wells coated with anti-Inhibin βA subunit antibody immobilized to the inside wall of each well. *DSL-10-28100 (4-plate) contains four (4) stripholders.\nInhibin A Standard A/Sample Diluent:\nOne vial, 2 mL each, labeled A, containing 0 pg/mL dimeric Inhibin A in fetal bovine serum with a nonmercury preservative. \n*DSL-10-28100 (4-plate) contains two (2) vials.\nInhibin A Standards:\nOne set of Standards, 1 mL each, labeled B-G, containing concentrations of approximately 10, 30, 100, 250, 500, and 1000 pg/mL dimeric Inhibin A in fetal bovine serum with a non-mercury preservative. \n*DSL-10-28100 (4-plate) contains two (2) sets of

• 關聯藥證數量: 1

Anti-Insulin-Coated Microtitration Strips: One stripholder containing 96 polystyrene microtiter wells with anti-Insulin antibody immobilized to the inside wall of each well.\nInsulin Standards: One vial labeled A, containing 0 μIU/ml Insulin and five vials, labeled B-F, containing concentrations of approximately 3.0, 10.0, 50.0, 100 and 300.0 μIU/ml Insulin in human serum.\nInsulin Controls: containing low and high concentrations of insulin in human serum.\nInsulin Antibody-Enzyme Conjugate Concentrate: containing 0.3 ml of anti-Insulin antibody conjugated to horseradish peroxidase in buffer.\nAssay Buffer B: containing a protein-based buffer.\nTMB Chromogen Solution: containing a solution of tetramethylbenzidine (TMB) in citrate buffer with hydrogen peroxide.\nWash Concentrate: containing buffered saline with a nonionic detergent.\nStopping Solution: containing 0.2 M sulfuric acid.\n

• 關聯藥證數量: 1

Anti-Jk is prepared from human blood containing appropriate antibodies, active by the indirect antiglobulin technique, bovine albumin in a sodium chloride solution.

• 關聯藥證數量: 1

Anti-Jka IgM Abs within 0.1%(w/v) NaN3 solution

• 關聯藥證數量: 1

Anti-Jkb IgM Abs within 0.1%(w/v) NaN3 solution

• 關聯藥證數量: 1

Anti-Jkb is prepared from human blood containing appropriate antibodies, active by the indirect antiglobulin technique. The final formulation includes bovine albumin in a sodium chloride solution.

• 關聯藥證數量: 1

Anti-Kappa, clone TB 28-2, is derived from hybridization of mouse P3-X63-Ag8.653 myeloma cells with cells from C,B6 (BC57b x BALB/c) mice immunized with human IgG-κmyeloma protein.

• 關聯藥證數量: 1

Anti-LH antibody-coated tubes: 2 x 50 tubes (ready-to-use)125I-labeied monoclonal anti-LH antibody: one 5.5 mL vial (ready-to use)The vial contains 370 kBq, at the date of manufacture, of 125Ilabeled immunoglobulins in buffer with bovine serum albumin, sodium azide (<0.1%; see § Precautions), and a dye.Standards: six vials (lyophilized)The standard vials contain from 0 to 180 IU/L of LH in horse serum with sodium azide (<0.1%, see § Precautions). The exact concentration is indicated on each vial. The standards were calibrated against the international standard WHO 2nd IS 80/552.Control sera: one vial (lyophilized)The vial contains human LH lyophilized in human serum (see § Precautions). The expected values are in the concentration range indicated on a supplement. Wash solution (20x): one 50 mL vialConcentrated solution has to be diluted before

• 關聯藥證數量: 1

Anti-LH antibody-coated tubes: 2 x 50 tubes. \nI-125-labeled monoclonal anti-LH antibody: The vial contains 370 kBq, of I-125-labled immunoglobulins in buffer with bovine serum albumin.\nStandards: The standard vials contain from 0 to 180 IU/L of LH in horse serum. \nControl sera: (lyophilized). The vial contains human LH lyophilized in human serum.\nWash solution (20x): Concentrated solution has to be diluted before use.

• 關聯藥證數量: 1

Anti-Lambda is composed of mouse IgG1 heavy chains and lambda light chains. The FITC conjugate is supplied as 12.5 μg in 1.0 ml (12.5 μg/ml) of phosphate-buffered saline (PBS) contains gelatin and 0.1% sodium azide.\n\n

• 關聯藥證數量: 1

Anti-Legionella pneumophila Staining Reagent\n？FITC-Labeled Monoclonal Antibody\n？Counterstain\n？Sodium Azide*\n？Protein-stabilized buffer

• 關聯藥證數量: 1

Anti-M IgG Abs within 0.1%(w/v) NaN3 solution

• 關聯藥證數量: 1

Anti-MPO is composed of mouse IgG1, heavy chains and kappa light chains.\nThe FITC conjugate is supplied as 12.5μg in 1.0 ml (12.5μg/ml) of phosphate-buffered saline (PBS).\nThe PE conjugate is supplied as 3μg in 1.0 ml (3μg/ml) of PBS. PBS contains gelatin and 0.1% sodium azide.\n

• 關聯藥證數量: 1

Anti-Mouse IgG F(ab’)2 FITC Conjugate: Affinity purified goat or sheep anti-mouse IgG F(ab’)2 antibodies conjugated to fluorescein isothiocyanate (FITC) are diluted in phosphate buffered saline with 0.75% protein stablilzer.

• 關聯藥證數量: 1

Anti-N IgG Abs within 0.1%(w/v) NaN3 solution

• 關聯藥證數量: 1

Anti-P1 (Murine Monoclonal) Gamma-clone is manufactured from IgM anti-P1 secreted by a murine hybridoma identified as OSK17. The final formulation includes a diluent containing phosphate-buffered saline and bovine albumin with a macromolecular compound added to potentiate and accelerate the specific agglutination reaction.

• 關聯藥證數量: 1

Anti-PSA monoclonal antibody coated tubes: 2 x 50 tubes Monoclonal 125I-labelled anti-PSA antibody: one 11 mL vial;The vial contains 580 kBq, at the date of manufacture, of 125I-labelled antibodyin buffer containing bovine serum albumin, sodium azide (<0.1 %) and a dye.Calibrators: five 0.8 mL vials and one 2 mL vial of <<zero>> calibrator The vials contain from 0 to 100 ng/mL of human PSA in buffer with bovine serumalbumin and sodium azide (<0.1 %). Control samples: two vials The vials contain human PSA lyophilized in bovine serum and sodium azide(<0.1 %). Wash solution (500x): one 1 mL vial

• 關聯藥證數量: 1

Anti-PTH [I-125] Reagent: \nTwo vials in DSL-8000 (100 Tubes) , 5.5 mL each, containing <10 μCi (370 kBq) per vial of [I-125]-labeled\nanti-PTH (1-34) in a protein-stabilized buffer and sodium azide as a preservative. \n* DSL-8000 (500 Tubes) contains ten (10) vials of reagent.\nI-PTH Controls:\nTwo vials containing low and high concentrations of I-PTH in a protein-based buffer with a non-mercury\npreservative.\n* DSL-8000 (500 Tubes) contains three sets of controls.\nWash Concentrate:\nOne bottle, 100 mL, containing buffered saline with a nonionic detergent. \n* DSL-8000 (500 Tubes) contains five bottles of wash concentrate.\n

• 關聯藥證數量: 1

Anti-S is prepared from human blood containing appropriate antibodies, active by the indirect antiglobulin technique. The final formulation includes bovine albumin in a sodium chloride solution.

• 關聯藥證數量: 1

Anti-T3 Antibody:One vial in DSL-3100 (100 Tubes), 11 mL each, containing anti-T3 mouse monoclonal antibody in a protein-based (BSA) buffer with sodium sodium azide as a preservative.*DSL-3100 (500 Tubes) contains five vials of antibody.T3 Controls:Two vials, 0.5 mL each, Level I and II, containing low and high concentrations of T3 in human serum with sodium azide as a preservative.Wash Concentrate: One bottle, 18 mL in DSL-3100 (100 Tubes), containing a concentrated buffered saline solution with sodium azide as preservative. *DSL-3100 (500 Tubes) contains one 90 mL-bottle of wash concentrate.

• 關聯藥證數量: 1

Anti-T3 monoclonal antibody-coated tubes：2 x 50 tubes 125I-labeled T3 tracer：one 55 mL vialThe vial contains 110 kBq, at the date of manufacture, of 125I-labeled T3 in buffer with proteins, sodium azide (<0.1%) and a dye.Control serum：two vialsThe vials contain T3 lyophilized in human seum.Calibrators：six 0.5 mL vialsThe calibrator vials contain from 0 to 12 nmol/L of T3 in human serum with sodium azide (<0.1%)

• 關聯藥證數量: 1

Anti-TG Ab Bead Pack：\ncoated with highly purified thyroglobulin.\nAnti-TG Ab Reagent Wedge：\n11.5 mL buffer matrix.11.5 mL alkaline phosphatase conjugated to monoclonal murine anti-human IgG antibody in buffer.\nAnti-TG Ab Adjustors：\nTwo vials (Low and High), of lyophilized TG autoantibodies in a human serum/buffer matrix.\nThyroid Autoantibody Sample Diluent：\n50 mL concentrated anti-TG/anti-TPO antibody-free buffer matrix.

• 關聯藥證數量: 1

Anti-TG Ab Test Units (LTG1)：Each barcode-labeled unit contains one bead coated with highly purified thyroglobulin.\nAnti-TG Ab Reagent Wedges(LTGA,LTGB)：LTGA：6.5 mL buffer matrix.\n LTGB：6.5 mL alkaline phosphate(bovine calf intestine)conjugated to a monoclonal murine anti-human IgG antibody in buffer.\nAnti-TG Ab Adjustors(LTGL,LTGH)：Two vials(Low and High), of lyophilized TG autoantibodies in a human serum/buffer matrix.\nThyroid Autoantibody Sample Diluent(LAAZ4)：For the manual dilution of patient sample.100 mL anti-TG/anti-TPO antibody-free buffer matrix.\n

• 關聯藥證數量: 1

Anti-TPO Ab Test Units:\ncoated with highly purified human TPO.\nAnti-TOP Ab Reagent Wedges:\nLTOA: one wedge (6.5 mL) of buffer matrix.\nLTOB: one wedge (6.5 mL) alkaline phosphatase (bovine calf intestine) conjugated to to a monoclonal murine anti-human IgG antibody in buffer.\nAnti-TPO Ab Adjustors:\nTwo vials (Low and High), of lyophilized TPO autoantibodies in a human serum/buffer matrix.\nThyroid Autoantibody Sample Diluent:\n100 mL anti-TG/anti-TPO antibody-free buffer matrix.

• 關聯藥證數量: 1

Anti-TSH antibody-coated tubes: 2 x 50 tubes125I-labeled monoclonal anti-TSH antibody: one 11 mL vial The vial contains 515 kBq. at the date of manufacture, of 125I-labeled immunoglobulins in buffer containing bovine serum albumin, sodium azide(<0.1%), and a dye.Calibrators: seven 1 mL vialsThe calibrator vials contain form 0 to 50 mIU/L of TSH in bovine serum with sodium azide (<0.1%) Control serums: two vialsThe vials contain TSH lyophilized in bovine serum.Wash solution (20x): one 50 mL vial

• 關聯藥證數量: 1

Anti-Viral Antibody Screening Reagent: Affinity purified mouse monoclonal antibodies directed against adenovirus; influenza A and B; parainfluenza type 1, 2 and 3; and RSV have been pooled as a specimen screening reagent. Antibodies are diluted in phosphate buffered saline (0.15 M sodium phosphate) with 0.75% protein stabilize. Sodium azide and thimerosal are added at concentrations of 0.1%as preservatives.

• 關聯藥證數量: 1

Anti-albumin antibody-coated tubes: 2 x 50 tubes\n125I-labeled albumin: one 55 mL vial\nThe vial contains 300 kBq, at the date of manufacture, of 125I-labeled albumin in buffer containing bovine serum albumin, sodium azide (＜0.1%). and a dye.\nAlbumin dilution buffer (4x): one 25 mL vial\nThe solution contains bovine serum albumin and sodium azide (＜0.1%).\nCalibrators: six 0.5 mL vials\nThe calibrator vials contain from 0 to 150 mg/L of albumin in buffer containing bovine serum albumin and sodium azide(＜0.1%).\nControl sample: one 0.5 mL vial\nThe vial contains albumin in buffer containing bovine serum albumin and sodium azide.

• 關聯藥證數量: 1

Anti-c IgM Abs within 0.1%(w/v) NaN3 solution

• 關聯藥證數量: 1

Anti-c(Monoclonal) Gamma-clone is manfactured from IgM antibodies of anti-c specificity, secreted by the human/murine heterohybridoma﹝2﹞identified as 951. Contains 0.1% sodium azide as a preservative.

• 關聯藥證數量: 1

Anti-e IgM Abs within 0.1%(w/v) NaN3 solution\n\n

• 關聯藥證數量: 1

Anti-e(Monoclonal)Gamma-clone is manufactured from a blend of IgM antibodies of anti-e specificity, secreted by the human/murine heterohybridomas identified as MS16, MS21 and MS63. Contains 0.1% sodium azide as a preservative.

• 關聯藥證數量: 1

Anti-ferritin monoclonal antibody-coated tubes: 2 x 50 tubes125I-labeled monoclonal anti-ferritin antibody: one 55 mL vial The vial contains 325 kBq of 125I-labeled immunoglobuins in buffer containing bovine serum albumin and a dye.Calibrators: five 0.5 mL vials and one 5 mL vial of <<zero>> calibratorThe calibrator vials contain from 0 to 1000 ng/mL of ferritin in buffer with bovine serum albumin.Control sera: two 0.5 mL vialsThe vials contain ferritin in human serum.Wash solution (20x): one 50 mL vial

• 關聯藥證數量: 1

Anti-hCG mouse monoclonal antibody coupled to colloidal gold particles+anti-hCG goat polyclonal antibody+goat anti-mouse IgG polyclonal antibody.

• 關聯藥證數量: 1

Anti-hCG-Coated Microtitration Strips：coated with anti-hCG antibody.\nI-hCG Standard A/Sample Diluent：containing 0 mIU/mL I-hCG in equine serum with sodium azide as a preservative.\nI-hCG Standards B-G：containing concentrations of approximately 3, 10, 30, 100, 300 and 1000 mIU/mL I-hCG in equine serum with sodium azide as a peservative.\nI-hCG Controls：containing low and high concentrations of I-hCG in equine serum with sodium azide as a preservative.\nAssay Buffer：(Green)：containing a protein-based (BSA) buffer with a non-mercury preservative.\nI-hCG Antibody-Enzyme Conjugate Concentrate：containing anti-hCG antibody conjugated to the enzyme horseradish peroxidase in a protein-based(BSA) buffer with a non-mercury preservative.\nTMB Chromogen Solution：containing a solution of tetramethylbenzidine (TMB) in citrate buffer with hydrogen peroxide.\nWash Concentrate：containing buffered saline with a nonionic detergent.\nStopping Solution：containing 0.2 M Sulfuric acid.

• 關聯藥證數量: 1

Anti-hFSH Coated Tubes\nhFSH Standards \nAnti-hFSH 125I\nWash Diluent (5X)\nAssay Diluent

• 關聯藥證數量: 1

Anti-hGH [I-125] Reagent:One bottle, 22 mL, containing <10 μCi (370 kBq) [I-125]-labeled anti-hGH antibody in a protein-based (BSA) buffer with sodium azide as a preservative.DSL-1900 (500 Tubes) contains five bottles of reagent.Anti-hGH-Coated Tubes:One hundred (100) plastic tubes with anti-hGH immunoglobulin immobilized to the inside wall of each tube. DSL-1900 (500 Tubes) contains 500 tubes:hGH Controls:Two vials, Levels I and II, containing low and high concentrations of hGH in human serum with a non-mercury preservative.DSL-1900 (500 Tubes) contains three sets of Controls.Wash Concentrate B:One bottle, 60 mL, containing buffered saline with a nonionic detergent. Dilute 25-fold with deionized water prior to use . DSL-1900 (500 Tubes) contains five bottles of Wash Concentrate.

• 關聯藥證數量: 1

Anti-hGH-Coated Microtitration Strips: One stripholder containing 96 microtitration wells coated with anti-hGH antibody.\nhGH Standards: Lyophilized.\nhGH Controls: Lyophilized.\nAssay Buffer: containing a protein-based (BSA) buffer with a non-mercury preservative.\nhGH Antibody-Enzyme Conjugate Concentrate: containing anti-hGH antibody conjugated to enzyme horseradish peroxidase in a protein-based (BSA) buffer with a non-mercury preservative.\nTMB Chromogen Solution: containing a solution of tetramethylbenzidine (TMB) in citrate buffer with hydrogen peroxide.\nWash Concentrate: containing buffered saline with a nonionic detergent.\nStopping Solution: containing 0.2 M sulfuric acid.\n

• 關聯藥證數量: 1

Anti-hLH monoclonal antibody (mouse)\nAnti-hLH monoclonal antibody (mouse) labeled with gold colloid.

• 關聯藥證數量: 1

Anti-human IgA(Goat)：18 mL

• 關聯藥證數量: 1

Anti-human IgG serum (goat) Titer: 3.5 unit Titer of antiserum is measured by Becker method. 1 mg/ml of Becker unit shall be 1 unit of titer.

• 關聯藥證數量: 1

Anti-human IgG: 18 mL

• 關聯藥證數量: 1

Anti-human IgM (Goat): 18 mL

• 關聯藥證數量: 1

Anti-phenobarbital monoclonal antibody (mouse).

• 關聯藥證數量: 1

Anti-prealbuminantibody coated particle Buffer Microbial inhibitros Polyethylene glycol Buffer Surfactant Microbial inhibitors

• 關聯藥證數量: 1

Anti-progesterone antibody coated tubes: 2x 50 tubes.125I-labeled progesterone: one 55 ml vial. The vial contains 185 kBq, at the date of manufacture, of 125I labeled progesterone with buffer and proteins.Standards: six 0.5 ml vials.The standard vials contain concentration of progesterone for a standard range from 0 to 60 ng/ml in human serum with sodium azide (0.1%).Control: one 0.5 ml vial. The vial contains progesterone in human serum with sodium azide(0.1%).

• 關聯藥證數量: 1

Anti-prolactin monoclonal antibody coated tubes: 2 x 50 tubes 125I-labeled monoclonal antibody: one 55 mL vial The vial contains 370 kBq, at the date of manufacture, of 125I-labeled immunoglobulins in buffer containing bovine serum albumin, sodium azide (<0.1%) and a dye.Calibrators: five vials + one 5 mL zero calibrator vialThe calibrator vials contain from 0 to 180 ng/mL of human prolactin in horse serum and sodium azide (<0.1%). The exact concentration is indicated on each vial.Control sera: two vialsThe vials contain human prolactin lyophilized in human serum. Wash solution (20X): one 50 mL vial

• 關聯藥證數量: 1

Anti-prolactin monoclonal antibody coated tubes: 2x 50 tubes.125I-labeled monoclonal antibody: one 55 ml vial. The vial contains 370 kBq, at the date of manufacture, of 125I labeled immunoglobulins in buffer containing bovine serum albumin, sodium azide (< 0.1%) and a dye.Standards: five vials (lyophilized) + one 5 ml zero standard vial. The standard vials contain from 0 to 180 ng/ml of human prolactin in horse serum and sodium azide (0.1%).Control sera: two vials (lyophilized). The vials contain human prolactin lyophilized in human serum.Wash solution (20x): one 50 ml vial.

• 關聯藥證數量: 1

Anti-theophylline monoclonal antibody (mouse) in buffer, pH7.5, with stabilizer and preservative.

• 關聯藥證數量: 1

Anti-vancomycin monoclonal antibody (mouse) in buffer, pH6.5, with stabilizer and preservative.

• 關聯藥證數量: 1

Antibodies from heterohybridoma MS201 and MS26.

• 關聯藥證數量: 1

Antibodies from：Birma-1, ES-4, ES-15.

• 關聯藥證數量: 1

Antibody Buffer (56 mL): Anti-HbA1c Antibodies (sheep) >0.5 mg/mLMES (2-morpholino-ethanesulfonic acid) Buffer (pH6.2) 0.05 mol/LPolyhapten Buffer (12 mL): HbA1c Polyhapten ≧20μg/mLHemoglobin Buffer (102 mL): Phosphate Buffer (pH 7.4) 0.02 mol/LCALIBRATOR CONSTITUENTS Hemolysate (human and sheep) 0.9% tetradecyltrimethylammonium bromide HEMOLYZING REAGENT (1000 mL)Tetradecyltrimethylammonium bromide: 9 g/L

• 關聯藥證數量: 1

Antibody Control (1.5ml). Lyophilized goat anti-rabbit serum containing a preservative.

• 關聯藥證數量: 1

Antibody From Hybridoma cell lines 16H8, 053A.714, 055A.305.

• 關聯藥證數量: 1

Antibody Reagent Contains: monoclonal anti-digoxin antibody in a buffer solution with sodium azide as a preservative. Microparticles Reagent Contains: digoxin coated microparticles suspension in an aqueous solution with sodium azide as a preservative. Calibrators: DRI Digoxin Negative Calibrator 1 x 5 mL (Contains 5 mL buffer solution with sodium azide as a preservative); DRI Digoxin 0.5 ng/mL Calibrator 1 x 2 mL (Contains 0.5 ng/mL Digoxin in buffer solution with sodium azide as a preservative); DRI Digoxin 1.0 ng/mL Calibrator 1 x 2 mL (Contains 1.0 ng/mL Digoxin in buffer solution with sodium azide as a preservative); DRI Digoxin 2.0 ng/mL Calibrator 1 x 2 mL (Contains 2.0 ng/mL Digoxin in buffer solution with sodium azide as a preservative); DRI Digoxin 3.0 ng/mL Calibrator 1 x 2 mL (Contains 3.0 ng/mL Digoxin in buffer solution with sodium azide as a preservative); DRI Digoxin 5.0 ng/mL Calibrator 1 x 2 mL (Contains 5.0 ng/mL Digoxin in buffer solution with sodium azide as a preservative).

• 關聯藥證數量: 1

Antibody latex: 2.5% w/v HbA1 c-specific mouse monoclonal antibody-latex in 10mM glycine buffer, 16% w/v non-reactive ingredients.\nAgglutinator: 0.005% w/v poly (aspartic acid) polymer, HbA 1c hapten in 20mM sodium citrate buffer containing 0.1% w/v bovine serum albumin, 1% w/v non-reactive ingredients.\nBuffer Solution: 8.1% w/v lithium thiocyanate, 0.01% digitonin in 200mM glycine buffer\nOxidant: 1.5% w/v potassium ferricyanide in water with 21% w/v non-reactive ingredients.

• 關聯藥證數量: 1

Antibody monospecific for human Transferrin (Goat): 18 mL

• 關聯藥證數量: 1

Antibody-coated microtiter plate with 96 wells.\nLyophilized CEA standards containing; 0, 3, 12, 30, 60, and 120ng/ml CEA. 1 set.\nEnzyme Conjugate Reagent\nTMB Reagent (One-Step)\nStop Solution (1N HCl)\n

• 關聯藥證數量: 1

Antibody-colloidal gold conjugate

• 關聯藥證數量: 1

Antibody/Substrate Reagent (1 x 25 mL) Contains monoclonal anti-acetaminophen antibody, glucose-6-phosphate (G6P) and nicotinamide adenine dinucleotide (NAD) in Tris buffer with sodium azide as preservative. Enzyme Conjugate Reagent (1 x 8 mL) Contains Acetaminophen labeled with glucose-6-phosphate dehydrogenase (G6PDH) in Tris buffer with sodium azide as a preservative. Acetaminophen Calibrator Kit (1 x 5 mL, 5 x 2 mL) Contains 5 mL of negative calibrator and 2 mL each of 10, 25, 50, 100 and 200 μg/mL acetaminophen calibrators in Tris buffer with sodium azide as a preservative.

• 關聯藥證數量: 1

Antibody/Substrate Reagent 1 (9C309UL/9C329UL) 115mL/1000mL\n Mouse Monoclonal antibodies to d-amphetamine and d-methamphetamine, bovine serum albumin, G6P, NAD, preservative and stabilizers\n \n Enzyme Reagent 2 (9C309UL/9C329UL) 50mL/435mL\n Amphetamines labeled with baterial Tris buffer, bovine serum albumin, preservatives and stabilizers. \n\n

• 關聯藥證數量: 1

Antibody/Substrate Reagent A (3 mL): sheep antibodies reactive to benzodiazepines (51 μg/mL), gIucose-6-phosphate (66 mM), nicotinamide adenine\ndinucleotide (40 mM), bulking agents, stabilizers, and preservatives.\n\nEnzyme Reagent B (3 mL): benzodiazepines labeled with bacterial glucose-6-phosphate dehydrogenase (0.48 U/mL), glucose-6-phosphate (32 mM), Tris buffer, bulking agents, stabilizers, and preservatives.\n\nEmit&reg; Drug Assay Buffer Concentrate (13.3 mL): Tris buffer, surfactant, and preservatives.\n

• 關聯藥證數量: 1

Antibody/Substrate Reagent(R1)：Contains monoclonal anti-MDMA antibody,glucose-6-phosphate(G6P), and nicotinamide adenine dinucleotide(NAD)in Tris buffer.\nEnzyme Conjugate Reagent(R2)：Contains MDMA labeled with glucose-6-phosphate dehydrogenase(G6PDH) in Tris buffer.\n

• 關聯藥證數量: 1

Antibody/Substrate Reagent. Contains mouse monoclonal anti-THC antibodies, glucose-6-phosphate, and nicotinamide adenine dinucleotide in Tris buffer.\nEnzyme Conjugate Reagent. Contains △9-THC labeled with glucose-6-phosphate dehydrogenase in Tris buffer.\n

• 關聯藥證數量: 1

Antibody/Substrate Reagent. \nContains monoclonal anti-primidone antibody, glucose-6-phosphate (G6P), and nicotinamide adenine dinucleotide (NAD) in Tris buffer.\nEnzyme Conjugate Reagent. Contains primidone derivative labeled with glucose-6-phosphate dehydrogenase (G6PDH) in Tris buffer.

• 關聯藥證數量: 1

Antibody/Substrate Reagent. contains mouse monoclonal anti-benzoylecgonine antibody, glucose-6-phosphate (G6P), and nicotinamide adenine dinucleotide (NAD) in Tris buffer.\nEnzyme Conjugate reagent. Contains benzoylecgonine analog labeled with glucose-6-ohisohate dehydrogenase (G6PDH) in HEPES buffer.

• 關聯藥證數量: 1

Antibody/Substrate Reagent.Contains monoclonal anti-morphine antibody,glucose-6-phosphate and nicotinamide adenine dinucleotide.\nEnzyme Conjugate Reagent.Contains morphine labeled with glucose-6-phosphate dehydrogenase.

• 關聯藥證數量: 1

Antibody/Substrate Reagent.\nContains monoclonal anti-barbiturate antibody, glucose-6-phosphate (G6P), and nicotinamide adenine dinucleotide (NAD) in Tris buffer with sodium azide as preservative.\n\nEnzyme Conjugate Reagent.\nContains barbiturate labeled with glucose-6-phosphate dehydrogenase (G6PDH) in Tris buffer with sodium azide as preservative.\n

• 關聯藥證數量: 1

Antibody/Substrate Reagent: 69 mL (Monoclonal anti-bonzoylecgonine antibody (mouse)/Glucose-6-phosphate (G6P)/ Nicotinamide adenine dinucleotide (NAD)/Tris buffer) \nEnzyme Conjugate Reagent: 18 mL (Glucose-6-phosphate dehydrogenase (G6PDH) labeled with benzoylecgonine/ Tris buffer) \n

• 關聯藥證數量: 1

Antibody/Substrate Reagent: 69 mL; Enzyme Conjugate Reagent: 18 mL

• 關聯藥證數量: 1

Antibody/Substrate Reagent: 69mL\nMonoclonal anti-Phencyclidine Antibody (mouse), Glucose-6-phosphate (G6P), Nicotinamide adenine dinucleotide (NAD), Tris buffer\nEnzyme Conjugate Reagent: 18mL\nGlucose-6-phosphate dehydrogenase(G6PDH) labeled with phencyclidine, Tris buffer\nAlso non-reactive chemicals necessary for optimal system performance\n

• 關聯藥證數量: 1

Antibody/Substrate Reagent: Contains anti-barbiturate antibodies, glucose-6-phosphate (G6P) and nicotinamide adenine dinucleotide (NAD) in Tris buffer with sodium azide as a preservative.\nEnzyme Conjugate Reagent: Contains barbituric acid derivative labeled with glucose-6-phosphate dehydrogenase (G6PDH) in Tris buffer with sodium azide as a preservative.

• 關聯藥證數量: 1

Antibody/Substrate Reagent: Contains anti-benzodiazepine antibodies, glucose-6-phosphate (G6P), and nicotinamide adenine dinucleotide (NAD) in Tris buffer with sodium azide as a preservative.\nEnzyme Conjugate Reagent: Contains benzodiazepine derivative labeled with glucose-6-phosphate dehydrogenase (G6PDH) in Tris buffer with sodium azide as a preservative.

• 關聯藥證數量: 1

Antibody/Substrate Reagent: Contains monoclonal anti-amphetamines antibodies, glucose-6-phosphate (G6P) and nicotinamide adenine dinucleotide (NAD) in Tris buffer with sodium azide as a preservative.Enzyme Conjugate Reagent: Contains amphetamines labeled with glucose-6-phosphate dehydrogenase (G6PDH) in Tris buffer with sodium azide as a preservative.

• 關聯藥證數量: 1

Antibody/Substrate Reagent: Contains monoclonal anti-methadone antibody, glucose-6-phosphate, and nicotinamide adenine dinucleotide.\nEnzyme Conjugate Reagent: Contains methadone derivative labeled with glucose-6-phosphate dehydrogenase .

• 關聯藥證數量: 1

Antibody/Substrate Reagent: Contains monoclonal anti-methaqualone antibodies, glucose-6-phosphate (G6P) and nicotinamide adenine nucleotide (NAD) in Tris buffer withsodium azide as a preservative.\nEnzyme Conjugate Reagent: Contains methaqualone labeled with glucose-6-phosphate dehydrogenase (G6PDH) in Tris buffer with sodium azide as a preservative.\n

• 關聯藥證數量: 1

Antibody/Substrate Reagent: Contains monoclonal anti-phencyclidine antibodies, glucose-6-phosphate (G6P) and nicotinamide adenine nucleotide (NAD) in Tris buffer with sodium azide as a preservative.\nEnzyme Conjugate Reagent: Contains phencyclidine labeled with glucose-6-phosphate dehydrogenase (G6PDH) in Tris buffer with sodium azide as a preservative.

• 關聯藥證數量: 1